ArticleBioinformatics (Oxford, England)2020
Towards reliable named entity recognition in the biomedical domain.
Article in Bioinformatics (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Breaking through the radiation dilemma: development and clinical translation of anti-radiation drugs.Pharmaceutical science advances · 2026Review
- Anonymization of Portuguese Clinical Notes Using Large Language Models and Quantum-Enhanced Hybrid Architectures: Comparative Evaluation Study.Journal of medical Internet research · 2026Article
- Large Language Model-Enhanced Drug Repositioning Knowledge Extraction via Long Chain-of-Thought: Development and Evaluation Study.JMIR medical informatics · 2025Article
- HunFlair2 in a cross-corpus evaluation of biomedical named entity recognition and normalization tools.Bioinformatics (Oxford, England) · 2024Article
- Improved self-training-based distant label denoising method for cybersecurity entity extractions.PloS one · 2024Article
- Zero-shot evaluation of ChatGPT for food named-entity recognition and linking.Frontiers in nutrition · 2024Article
- From language models to large-scale food and biomedical knowledge graphs.Scientific reports · 2023Article
- Article
- AIONER: all-in-one scheme-based biomedical named entity recognition using deep learning.Bioinformatics (Oxford, England) · 2023Article
- Identifying stroke diagnosis-related features from medical imaging reports to improve clinical decision-making support.BMC medical informatics and decision making · 2022Article
- Deep learning-based methods for natural hazard named entity recognition.Scientific reports · 2022Article
- Hierarchical shared transfer learning for biomedical named entity recognition.BMC bioinformatics · 2022Article
- RLAS-BIABC: A Reinforcement Learning-Based Answer Selection Using the BERT Model Boosted by an Improved ABC Algorithm.Computational intelligence and neuroscience · 2022Article
- Negation and uncertainty detection in clinical texts written in Spanish: a deep learning-based approach.PeerJ. Computer science · 2022Article
- How Do Your Biomedical Named Entity Recognition Models Generalize to Novel Entities?IEEE access : practical innovations, open solutions · 2022Article
- Article
- OnTheFlyNAR genomics and bioinformatics · 2021Article
- AI-based language models powering drug discovery and development.Drug discovery today · 2021Review
- Text Mining for Building Biomedical Networks Using Cancer as a Case Study.Biomolecules · 2021Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
motivationAutomatic biomedical named entity recognition (BioNER) is a key task in biomedical information extraction. For some time, state-of-the-art BioNER has been dominated by machine learning methods, particularly conditional random fields (CRFs), with a recent focus on deep learning. However, recent work has suggested that the high performance of CRFs for BioNER may not generalize to corpora other than the one it was trained on. In our analysis, we find that a popular deep learning-based approach to BioNER, known as bidirectional long short-term memory network-conditional random field (BiLSTM-CRF), is correspondingly poor at generalizing. To address this, we evaluate three modifications of BiLSTM-CRF for BioNER to improve generalization: improved regularization via variational dropout, transfer learning and multi-task learning.
resultsWe measure the effect that each strategy has when training/testing on the same corpus ('in-corpus' performance) and when training on one corpus and evaluating on another ('out-of-corpus' performance), our measure of the model's ability to generalize. We found that variational dropout improves out-of-corpus performance by an average of 4.62%, transfer learning by 6.48% and multi-task learning by 8.42%. The maximal increase we identified combines multi-task learning and variational dropout, which boosts out-of-corpus performance by 10.75%. Furthermore, we make available a new open-source tool, called Saber that implements our best BioNER models. AVAILABILITY AND IMPLEMENTATION: Source code for our biomedical IE tool is available at https://github.com/BaderLab/saber. Corpora and other resources used in this study are available at https://github.com/BaderLab/Towards-reliable-BioNER. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.